Here are a few symptoms worth flagging to your GP, AF nurse, or cardiologist: New or worsening palpitations, especially if episodes feel longer or more frequent than usual A faster-than-usual resting heart rate, if you check it Light-headedness or dizziness, especially when standing up Increased breathlessness on exertion compared with your baseline An AF episode thats harder to break than usual or doesnt respond to your usual rescue plan None of these is an emergency on its own, unless symptoms are severe
In women with polycystic ovary syndrome (PCOS) and obesity, GLP-1 therapy has shown promise in improving reproductive hormone profiles, though this represents an off-label use with limited evidence
Another option is tirzepatide
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
3 That would imply that GLP-1 works to moderate the movement of foods in order to maximize the absorption of nutrients, a process which also contributes to a reduction in appetite and a benefit to healthy weight management
